XML 87 R68.htm IDEA: XBRL DOCUMENT v3.10.0.1
INVESTMENTS - Narrative (Details) - USD ($)
$ in Thousands, shares in Millions
12 Months Ended
Dec. 02, 2016
Jul. 26, 2016
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Dec. 01, 2016
Schedule of Equity Method Investments [Line Items]            
Impairment recognized     $ 5,002 $ 0 $ 0  
Remeasurement gain attributable to acquisition of Innovatix, LLC     $ 0 $ 205,146 $ 0  
Innovatix            
Schedule of Equity Method Investments [Line Items]            
Business combination, equity interest in acquiree, percentage 50.00%     50.00%   50.00%
Business acquisition, percentage of voting interests acquired 50.00%          
Remeasurement gain attributable to acquisition of Innovatix, LLC $ 205,100     $ 205,100    
Premier Supply Chain Improvement, Inc | Innovatix            
Schedule of Equity Method Investments [Line Items]            
Business combination, equity interest in acquiree, percentage           50.00%
Business acquisition, percentage of voting interests acquired 50.00%          
FFF | Premier Supply Chain Improvement, Inc            
Schedule of Equity Method Investments [Line Items]            
Subsidiary ownership interest   49.00%        
Cash payment for acquisition   $ 65,700        
Purchase price   81,100        
Aggregate equity grant value of restricted stock units   $ 15,400        
Bloodbuy | Premier Supply Chain Improvement, Inc | Common Class B Unit            
Schedule of Equity Method Investments [Line Items]            
Subsidiary ownership interest     15.00% 15.00%    
Common limited partners units acquired (in shares)     5.3 5.3    
PharmaPoint            
Schedule of Equity Method Investments [Line Items]            
Impairment recognized     $ 4,000      
PharmaPoint | Premier Supply Chain Improvement, Inc | Common Class B Unit            
Schedule of Equity Method Investments [Line Items]            
Subsidiary ownership interest     28.00% 28.00%    
Common limited partners units acquired (in shares)     5.0 5.0